Ok Biotech (Taiwan) Buy Hold or Sell Recommendation
| 4155 Stock | 24.00 0.30 1.27% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Ok Biotech Co is 'Cautious Hold'. Macroaxis provides Ok Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 4155 positions. The advice algorithm takes into account all of Ok Biotech's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Ok Biotech's buy or sell advice are summarized below:
Real Value 20.39 | Hype Value 24 | Market Value 24 | Naive Value 23.61 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Ok Biotech Co given historical horizon and risk tolerance towards Ok Biotech. When Macroaxis issues a 'buy' or 'sell' recommendation for Ok Biotech Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
4155 |
Execute Ok Biotech Buy or Sell Advice
The 4155 recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ok Biotech Co. Macroaxis does not own or have any residual interests in Ok Biotech Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ok Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Ok Biotech Trading Alerts and Improvement Suggestions
| Ok Biotech generated a negative expected return over the last 90 days | |
| About 24.0% of the company shares are owned by insiders or employees |
Ok Biotech Returns Distribution Density
The distribution of Ok Biotech's historical returns is an attempt to chart the uncertainty of Ok Biotech's future price movements. The chart of the probability distribution of Ok Biotech daily returns describes the distribution of returns around its average expected value. We use Ok Biotech Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ok Biotech returns is essential to provide solid investment advice for Ok Biotech.
| Mean Return | -0.05 | Value At Risk | -1.59 | Potential Upside | 1.42 | Standard Deviation | 0.94 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ok Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ok Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ok Biotech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ok Biotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a 4155 stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.06 | |
β | Beta against NYSE Composite | 0.03 | |
σ | Overall volatility | 0.96 | |
Ir | Information ratio | -0.12 |
Ok Biotech Volatility Alert
Ok Biotech Co exhibits very low volatility with skewness of 0.25 and kurtosis of 1.22. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ok Biotech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ok Biotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Ok Biotech Fundamentals Vs Peers
Comparing Ok Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ok Biotech's direct or indirect competition across all of the common fundamentals between Ok Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ok Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ok Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ok Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ok Biotech to competition |
| Fundamentals | Ok Biotech | Peer Average |
| Return On Equity | 0.0799 | -0.31 |
| Return On Asset | 0.0155 | -0.14 |
| Profit Margin | 0.1 % | (1.27) % |
| Operating Margin | 0.05 % | (5.51) % |
| Current Valuation | 3.01 B | 16.62 B |
| Shares Outstanding | 95.67 M | 571.82 M |
| Shares Owned By Insiders | 23.77 % | 10.09 % |
| Shares Owned By Institutions | 0.47 % | 39.21 % |
| Price To Book | 1.49 X | 9.51 X |
| Price To Sales | 1.71 X | 11.42 X |
| Revenue | 1.26 B | 9.43 B |
| Gross Profit | 186.83 M | 27.38 B |
| EBITDA | 110.1 M | 3.9 B |
| Net Income | 43.46 M | 570.98 M |
| Total Debt | 401.76 M | 5.32 B |
| Book Value Per Share | 18.46 X | 1.93 K |
| Cash Flow From Operations | 21.9 M | 971.22 M |
| Earnings Per Share | 1.34 X | 3.12 X |
| Number Of Employees | 5 | 18.84 K |
| Beta | 0.38 | -0.15 |
| Market Capitalization | 3.21 B | 19.03 B |
| Total Asset | 2.81 B | 29.47 B |
| Z Score | 4.2 | 8.72 |
| Annual Yield | 0.03 % | |
| Net Asset | 2.81 B | |
| Last Dividend Paid | 1.0 |
Ok Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as 4155 . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ok Biotech Buy or Sell Advice
When is the right time to buy or sell Ok Biotech Co? Buying financial instruments such as 4155 Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ok Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Makers Thematic Idea Now
Chemicals Makers
Companies developing chemicals for crops, soil as well as human, and animals. The Chemicals Makers theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Makers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Ok Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for 4155 Stock analysis
When running Ok Biotech's price analysis, check to measure Ok Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ok Biotech is operating at the current time. Most of Ok Biotech's value examination focuses on studying past and present price action to predict the probability of Ok Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ok Biotech's price. Additionally, you may evaluate how the addition of Ok Biotech to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |